Aethlon Medical to provide data on HVC individuals treated using its Hemopurifier at the 42nd ASN meeting Aethlon Medical, Inc. Dr. The event is being held at The San Diego Convention Center in San Diego, California. We are honored that Dr. Kher provides been invited to travel from India to provide our scientific data at the largest annual gathering of Nephrologists, stated Aethlon Chairman and CEO, Jim Joyce. In HCV care, these devices targets to boost patient cure rates as an adjunct to accelerate and enhance the functionality of current and future iterations of standard of care medication therapy..Difficile infections linked to a previous stay static in the survey medical center within 28 times before specimen collection, or infections linked to a prior hospitalization in the survey hospital within the preceding 48 hours. Statistical Analysis Data were analyzed with the use of SAS software, version 9.3 , and OpenEpi software program, versions 2.3.1 and 3.01 .34 This data source of hospitalizations from an example of U.S. Community hospitals originated as part of the Healthcare Cost and Utilization Project of the Company for Healthcare Analysis and Quality; discharge weighting allows nationwide estimates to be produced from the sample.